<<

Cutaneous : A Case of Bullous

Ermira Vasili, MD; Irena Savo, MD; Xhiliola Doci, MD; Entela Shkodrani, MD; Asimo Ntemoy, MD

Mastocytosis is characterized by an increased Case Report number of mast cells with abnormal growth and A 4-month-old male infant was referred to the accumulation in 1 or more organs. In children, clinic for evaluation of a generalized mastocytosis is commonly cutaneous and patients bullous eruption of 3 months’ duration that was present with a spectrum of findings, ranging from associated with erythematous and hyperpigmented solitary or multiple to urticaria macules, urticarial elements, and itching localized on pigmentosa (UP) or diffuse cutaneous mastocyto- the trunk, extremities, and buttocks. The condition sis (CM). We present a case of a 4-month-old gradually became aggravated with the appearance of infant with bullous UP. bullous elements that began increasing in number in Cutis. 2013;91:70-72. the 2 weeks prior to presentation. The patient previ- ously had been treated by a pediatrician who admin- istered topical and oral , which led to he term mastocytosis includes a heterogeneous transient improvements. group of disorders characterizedCUTIS by excessive Clinical examination revealed multiple tense Tmast cell proliferation and accumulation in bullae on the bilateral upper and lower extremi- tissues. These diseases can be limited to the ties and trunk, some surrounded by erythema, mul- (cutaneous mastocytosis [CM]) or involve extracuta- tiple crusts, hyperpigmented macules, and neous tissues (systemic mastocytosis). Cutaneous mas- (Figure 1). Scratch tests revealed immediate marked tocytosis is more common and approximately 75% of dermographism. The Darier sign also was observed. cases occur before 2 years of age.1 Children with CM There was no family history of dermatologic disease. typicallyDo present with a spectrum Not of findings, ranging The patient’sCopy physical and psychomotor develop- from solitary or multiple mastocytomas to urticaria ment was unaffected. Laboratory evaluation revealed pigmentosa (UP) or diffuse CM. Blistering may occur a complete blood cell count within reference range. in infants, particularly those with UP or diffuse CM. A radiologic skeletal survey also was performed; no We present the case of a 4-month-old male infant abnormal findings were present. Abdominal ultra- who was diagnosed with bullous UP, an aggressive sonography did not show any hepatosplenomeg- form of UP that overlaps with bullous mastocytosis. aly or lymphadenopathy. The fluid from the bullae Bullous UP primarily affects infants, and despite was sterile. its alarming appearance, its resolution typically Histopathologic examination of lesional skin is spontaneous.1 showed subepidermal bullae and infiltration of numerous mast cells in the papillary and reticu- lar (Figure 2). Metachromatic stain demon- strated granules that were bluish purple. Anti–c- (CD117) staining, which has a high speci- Drs. Vasili, Savo, and Shkodrani are from the Department ficity and sensitivity for mast cells, also was performed of Dermatovenerology, University Hospital Center Mother (Figure 3). A few eosinophils and neutrophils also Theresa, Tirana, Albania. Dr. Doci is from the Department of were present in the dermis. Dermatovenerology, Durrës Regional Hospital, Albania. Dr. Ntemoy Based on the clinical and histologic findings, is from the Department of Anatomopathology, General Hospital of positive Darier sign, and absence of systemic involve- Ioannina G. Hatzikosta, Ioannina, Greece. The authors report no conflict of interest. ment, the diagnosis of CM in the form of bullous Correspondence: Xhiliola Doci, MD, Spitali Rajonal Durrës, L: 8, RR: UP was made. Symptomatic treatment with topical A. Goga, Durrës, Albania ([email protected]). and oral antihistamines (H1 blockers) was effective.

70 CUTIS® WWW.CUTIS.COM Copyright Cutis 2013. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. Cutaneous Mastocytosis

Figure 2. Skin specimen from the lesion on the patient’s left forearm showed infiltration of mast cells in the dermis (H&E, original magnification 10). CUTISA

B FigureDo 1. Hyperpigmented macules, Not bullae, and urti- Copy carial elements localized on the trunk (A) and upper Figure 3. CD117 stain with a high specificity and sensi- extremity (B). tivity for mast cells (original magnification 20).

Improvement was noted during follow-up examina- mastocytosis are caused by induced or spontaneous tion at 6 and 12 months with regression of bullous activation of mast cells, resulting in the release of vaso- elements but persistence of hyperpigmented macules active mediators such as , arachidonic acid and positive Darier sign. metabolites (eg, prostaglandin D2, C4), proteases, and cytokines. Therefore, patients with Comment mastocytosis often report recurrent , ana- Mastocytosis is characterized by an increased number phylaxis, and gastrointestinal tract symptoms such as of mast cells with abnormal growth and accumula- cramping and . In children, mastocytosis is tion in 1 or more organs. An excessive number of commonly cutaneous and often transient when com- mast cells can be found in the skin, bone marrow, pared to adults who usually present with progressive , , lymph nodes, and/or gastrointestinal and systemic disease.3 Almost all patients with CM tract. The fundamental pathogenesis of mastocytosis belong in the indolent category of mastocytosis and is largely unknown. Mast cells express the recep- thus have a good prognosis.4 Cutaneous mastocystosis tor for factor, the tyrosine kinase of infancy and childhood frequently involutes spon- c-kit (CD117). Activated of c-kit have taneously, which is not the case with CM in adults.5 been implicated in the pathogenesis of both CM and Generally, there are 3 more common forms systemic mastocytosis.2 Symptoms in patients with of CM in children: maculopapular CM (UP),

WWW.CUTIS.COM VOLUME 91, FEBRUARY 2013 71 Copyright Cutis 2013. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher. Cutaneous Mastocytosis

of skin, and diffuse CM.4 Urticaria Conclusion pigmentosa may be present at birth and has been Bullous UP and bullous CM should be considered reported to appear in infancy and childhood at a in the in patients presenting median age of 2.5 months. By adolescence, symptoms with a bullous eruption of the skin. Our case helps to gradually improve and resolve in approximately document the diagnosis of CM in the pediatric pa- 50% of patients.6 Lesions are well-demarcated, red- tient population. brown, slightly elevated plaques averaging 0.5 to 1.5 cm in diameter and localized on any surface REFERENCES except for the palms and soles.5 Itching, flushing, and 1. Braun-Falco O, Plewig G, Burgdorf WHC, et al. Masto- dermographism typically occur. Darier sign, the wheal cytoses. In: Braun-Falco O, Plewig G, Burgdorf WHC, and flare reaction observed following brisk stroking et al. Dermatology. 2nd ed. New York, NY: Springer-Verlag; of the lesions, can be elicited. Infants may develop 2000:1649-1656. bullae and vesicles until 2 years of age; bullae rarely 2. Castells MC, Akin C. Clinical manifestations, patho- are observed in older patients. Bullous UP is best genesis, and classification of mastocytosis (cutaneous and classified as an extreme form of UP that is difficult to systemic). UpToDate. http://www.uptodate.com/contents distinguish from bullous mastocytosis, which is a form /clinical-manifestations-pathogenesis-and-classification- of diffuse CM. Marked mediator release leads to recur- of-mastocytosis-cutaneous-and-systemic. Updated May 11, rent formation.1 Blistered areas usually heal 2012. Accessed January 17, 2013. without scar formation, unless the lesions become 3. Middelkamp Hup MA, Heide R, Tank B, et al. Comparison secondarily infected. Extensive bullae can cause con- of mastocytosis with onset in children and adults. J Eur Acad fusion and the development of other bullous diseases, Dermatol Venereol. 2002;16:115-120. such as scalded skin syndrome and bullous erythema 4. Valent P, Horny HP, Escribano L, et al. Diagnostic criteria multiforme.7 Bullous UP also might be differentiated and classification of mastocytosis: a consensus proposal. from bullous , , Leuk Res. 2001;25:603-625. epidermolytic , , 5. Wolff K, Komar M, Petzelbauer P. Clinical and histo- and congenital syphilis.8,9 pathological aspects of cutaneous mastocytosis. Leuk Res. The diagnosis of UP wasCUTIS made in our patient 2001;25:519-528. based on the clinical and histopathologic findings. 6. Habif TP. Mastocytosis. In: Habif TP, ed. Clinical Elevated plasma histamine levels are demonstrated in Dermatology: A Color Guide to Diagnosis and Therapy. 4th ed. most children with mastocytosis, especially in those London, England: Mosby; 2004:156-161. with diffuse CM. Histamine levels may be useful for 7. Golitz LE, Weston WL, Lane AT. Bullous mastocytosis: dif- identifying children at risk for gastrointestinal tract fuse cutaneous mastocytosis with extensive mimick- ulceration. Urinary histamine metabolites are more ing scalded skin syndrome or erythema multiforme. Pediatr sensitiveDo than plasma histamine Not and also correlate Dermatol.Copy 1984;l:288-294. with bone marrow involvement. Serum 8. Pielop JA. Vesiculobullous and pustular lesions in levels are useful in the follow-up of patients with sys- the newborn. UpToDate. http://www.uptodate.com temic mastocytosis.10 /contents/vesiculobullous-and-pustular-lesions-in-the- Management of the disease is symptom- newborn?sourcesearch_result&searchvesiculobullous atic, as it is not possible to eradicate the disease.11 andpustularlesions&selectedTitle1%7E150. Updated Symptomatic therapies include H1 receptor blockers January 24, 2012. Accessed January 17, 2013. (eg, antihistamines, clemastine, , cromo- 9. Chandra P, Velazquez E. Differential diagnosis of bullous glicic acid); H2 receptor blockers (eg, ranitidine); skin lesions in the pediatric population [published online for flushes, , or fainting; and ade- ahead of print June 28, 2008]. J Cutan Pathol. 2005;32:80. quate calcium and vitamin D intake. Aspirin should 10. Kiszewski AE, Durán-Mckinster C, Orozco-Covarrubias be used with caution to avoid a hypotensive crisis.12 L, et al. Cutaneous mastocytosis in children: a clinical Preventative measures in systemic and extensive analysis of 71 cases. J Eur Acad Dermatol Venereol. 2004;18: cases of CM in children are strongly recommended, 285-290. including prevention of anaphylactic or anaphy- 11. Katsamba AD, Karpouzis AJ, Koumantaki-Mathioudaki E, lactoid reactions in general; elimination of provok- et al. Mastocytosis with skin manifestations: current status. J ing factors; and avoidance of aspirin, nonsteroidal Eur Acad Dermatol Venereol. 1999;13:155-165. anti-inflammatory drugs, codeine, and polymyxin B. 12. Heide R, Beishuizen A, De Groot H, et al; Dutch National In patients with isolated cases of CM, regular 6- to Mastocytosis Work Group. Mastocytosis in children: a pro- 12-month follow-up is recommended.12 tocol for management. Pediatr Dermatol. 2008;25:493-500.

72 CUTIS® WWW.CUTIS.COM Copyright Cutis 2013. No part of this publication may be reproduced, stored, or transmitted without the prior written permission of the Publisher.